Literature DB >> 27595359

Leukemia.

Gunnar Juliusson, Rachael Hough.   

Abstract

Leukemias are a group of life threatening malignant disorders of the blood and bone marrow. In the adolescent and young adult (AYA) population, the acute leukemias are most prevalent, with chronic myeloid leukemia being infrequently seen. Factors associated with more aggressive disease biology tend to increase in frequency with increasing age, whilst tolerability of treatment strategies decreases. There are also challenges regarding the effective delivery of therapy specific to the AYA group, consequences on the unique psychosocial needs of this age group, including compliance. This chapter reviews the current status of epidemiology, pathophysiology, treatment strategies and outcomes of AYA leukemia, with a focus on acute lymphoblastic leukemia and acute myeloid leukemia.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27595359     DOI: 10.1159/000447076

Source DB:  PubMed          Journal:  Prog Tumor Res        ISSN: 2296-1887


  52 in total

Review 1.  MicroRNAs as prognostic biomarker and relapse indicator in leukemia.

Authors:  S Hajizamani; M Shahjahani; S Shahrabi; N Saki
Journal:  Clin Transl Oncol       Date:  2017-03-07       Impact factor: 3.405

2.  Comparison of the anxiety, depression and their relationship to quality of life among adult acute leukemia patients and their family caregivers: a cross-sectional study in China.

Authors:  Ying Wang; Jie Yan; JingYi Chen; ChunFeng Wang; YingChun Lin; Yong Wu; Rong Hu
Journal:  Qual Life Res       Date:  2021-02-17       Impact factor: 4.147

3.  Elevated plasma phage load as a marker for intestinal permeability in leukemic patients.

Authors:  Xue-Rui Yin; Ping Liu; Xi Xu; Ying Xia; Kai-Zhao Huang; Qiong-Dan Wang; Mei-Mei Lai; Qi-Gui Yu; Xiao-Qun Zheng
Journal:  Med Microbiol Immunol       Date:  2020-09-29       Impact factor: 3.402

4.  Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cells.

Authors:  Xiaobin Wang; Xiaoyu Liu; Huihan Wang
Journal:  Cancer Gene Ther       Date:  2022-06-29       Impact factor: 5.987

5.  Maternal diabetes and risk of childhood malignancies in the offspring: a systematic review and meta-analysis of observational studies.

Authors:  Pengfei Yan; Yongbo Wang; Xue Yu; Yu Liu; Zhi-Jiang Zhang
Journal:  Acta Diabetol       Date:  2020-09-11       Impact factor: 4.280

6.  Spontaneous Resolution of Foveal Sub-internal Limiting Membrane Hemorrhage with Excellent Visual and Anatomical Outcome in a Patient with Acute Myeloid Leukemia.

Authors:  Osama Saeed Alamri; Raed Eid Alsulami; Bader Saad Alqahtani; Abdullah Alqahtani
Journal:  Middle East Afr J Ophthalmol       Date:  2020-04-29

Review 7.  Telomere Length and Hematological Disorders: A Review.

Authors:  Beatriz Maria Dias Nogueira; Caio Bezerra Machado; Raquel Carvalho Montenegro; Maria Elisabete Amaral DE Moraes; Caroline Aquino Moreira-Nunes
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 8.  The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunities.

Authors:  Nithya Mudgapalli; Palanisamy Nallasamy; Haritha Chava; Srinivas Chava; Anup S Pathania; Venugopal Gunda; Santhi Gorantla; Manoj K Pandey; Subash C Gupta; Kishore B Challagundla
Journal:  Mol Aspects Med       Date:  2019-10-14

9.  LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613.

Authors:  Qiying Yao; Li Zhang; Yuchuan Wang; Junli Liu; Liu Yang; Yingjie Wang
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

10.  Hirsutanol A inhibits T-acute lymphocytic leukemia Jurkat cell viability through cell cycle arrest and p53-dependent induction of apoptosis.

Authors:  Fangfang Zhong; You Yang; Danwei Ren; Sili Long; Xiang Qin; Jing Liu; Yan Zeng; Wenjian Lan; Wenzhe Ma; Wenjun Liu
Journal:  Exp Ther Med       Date:  2021-05-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.